{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-098224","form_type":"8-K","ticker":"TTRX","cik":"0002023016","company_name":"Turn Therapeutics Inc.","filed_at":"2026-09-09T12:10:15+00:00","discovered_at":"2026-09-09T12:15:00.369656+00:00","generated_at":"2026-09-09T12:15:05.351203+00:00","sec_items":["7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Turn Therapeutics appoints former CDC Director Robert Redfield as Chief Scientific Officer","bullets":["Robert R. Redfield, M.D., former CDC Director, named Chief Scientific Officer effective Sept 9, 2026.","Redfield brings 40+ years in immunology, infectious disease; cited >40,000 times in scientific literature.","He will lead scientific strategy for GX-03 across atopic dermatitis, onychomycosis, hidradenitis suppurativa.","Redfield will work with CEO Bradley Burnam and former FDA Commissioner Stephen Hahn.","Company is clinical-stage biotech developing non-systemic therapies for inflammatory skin diseases."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-098224","json":"https://secwatch.observer/filing/0001213900-26-098224.json","markdown":"https://secwatch.observer/filing/0001213900-26-098224.md","text":"https://secwatch.observer/filing/0001213900-26-098224.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2023016/000121390026098224/0001213900-26-098224-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2023016/000121390026098224/ea0304806-8k_turn.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-09T12:15:05.351203+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}